Ivory Secures $1M to Build India’s First Scalable Brain Health Platform

How a HealthTech Startup is Turning Cognitive Screening into Preventive Healthcare

In the rapidly evolving world of digital healthcare, preventive diagnostics are becoming the cornerstone of modern medicine. While millions of people regularly monitor physical health indicators like blood pressure, glucose levels, and heart rate, brain health has largely remained an overlooked frontier.

Bengaluru-based healthtech startup Ivory is working to change that. The company recently raised $1 million in fresh funding to strengthen its technology stack and expand its clinical capabilities—signaling rising investor interest in digital platforms focused on cognitive health and early neurological screening.

With its neuroscience-driven platform, Ivory aims to make cognitive screening as routine as traditional health checkups, helping millions identify early signs of cognitive decline and take proactive steps toward better brain health.

A Startup Focused on Preventive Brain Health

Founded by Issac John and Rahul Krishnan, Ivory is a brain-health platform that focuses on early detection and proactive cognitive care. The startup integrates neuroscience, neuropsychology, and digital health technologies to help individuals understand and improve their cognitive well-being.

The company’s platform offers clinical-grade cognitive assessments that measure key brain functions such as:

• Memory
• Attention
• Executive function
• Processing speed

Through its digital app and assessment tools, Ivory provides personalized insights, brain-training exercises, and recommendations that help users monitor and optimize their cognitive health over time.

This approach addresses a major gap in healthcare systems worldwide: cognitive impairments often go undiagnosed until symptoms become severe, limiting opportunities for early intervention.

Funding Details and Investors

Ivory’s latest funding round raised $1 million in seed capital from a group of prominent investors in healthcare and deep technology.

The investors participating in the round include:

• Draper Associates, a global venture capital firm known for backing breakthrough technology startups
• SAGE Venture Fund, an alternative investment fund launched by the Ministry of Social Justice and Empowerment (MoSJE)
• IFCI Venture, a subsidiary of IFCI Limited and SIDBI

The investment reflects growing confidence among institutional investors in preventive healthcare startups capable of delivering large-scale public health impact.

According to the company, the new funding will be used to:

• Strengthen its technology infrastructure
• Expand clinical research capabilities
• Enhance product development
• Build scalable and evidence-based cognitive screening solutions

These initiatives aim to position Ivory as a leading brain-health technology platform in India.

The “Treadmill Test” for the Brain

One of Ivory’s most innovative concepts is what it describes as a “treadmill test for the brain.”

Just as a treadmill test evaluates cardiovascular performance under controlled stress conditions, Ivory’s digital assessments measure how the brain performs across different cognitive tasks. These tests analyze various mental functions, enabling users to track their brain performance over time.

This model transforms cognitive testing from a one-time clinical evaluation into a continuous monitoring process, making it easier to detect early warning signs of neurological decline.

With the rising prevalence of conditions such as dementia and Alzheimer’s disease, early screening tools like these could play a crucial role in improving long-term outcomes.

Expanding Partnerships in the Healthcare Ecosystem

To scale its technology across India’s healthcare landscape, Ivory has begun building strategic partnerships with diagnostic and healthcare providers.

Recently, the startup partnered with Metropolis Healthcare, a major diagnostic laboratory chain, to launch the TruHealth Mind & Body package. This integrated preventive health offering combines traditional pathology diagnostics with neuroscience-based cognitive assessments.

The collaboration represents an important step toward integrating cognitive health into routine preventive health checkups, something that has historically been absent from traditional medical screening packages.

Addressing India’s Cognitive Health Gap

Despite growing awareness around mental health and wellness, cognitive health screening remains uncommon in India. Most individuals seek neurological testing only after noticeable symptoms appear.

Ivory aims to change this by making brain health monitoring accessible, digital, and proactive.

The platform helps individuals track cognitive health indicators alongside other vital health metrics, encouraging earlier diagnosis and lifestyle interventions.

Healthcare experts believe such solutions could significantly reduce the burden of neurodegenerative diseases by enabling early detection and preventive treatment strategies.

The Future of Brain Health Technology

Globally, preventive healthcare and longevity science are attracting increasing investment. As populations age and awareness around neurological diseases grows, brain health is emerging as a major frontier in digital health innovation.

Ivory’s long-term vision is to embed cognitive screening across multiple healthcare touchpoints, including:

• Diagnostic laboratories
• Corporate wellness programs
• Insurance health assessments
• Longevity and preventive care platforms

By integrating neuroscience with data-driven insights, the company hopes to create a comprehensive ecosystem for cognitive wellness.

Conclusion

Ivory’s latest $1 million funding round marks a significant step forward in the evolution of preventive healthcare in India. By focusing on early cognitive screening and proactive brain health management, the startup is addressing one of the most overlooked aspects of human health.

As digital health technologies continue to transform the medical landscape, Ivory’s mission to make brain health measurable, trackable, and actionable could redefine how individuals and healthcare systems approach cognitive well-being.

If successful, the company may help ensure that brain health becomes as routinely monitored as heart health or blood pressure in the years ahead.